West Virginia University
Burkholderia Collagen-Like Protein 8, Bucl8, Is an Outer-Membrane Component of a Novel Efflux Pump and Immunogenic Vaccine Candidate
Abstract
dc:description.abstractBurkholderia spp. are Gram‐negative intrinsically resistant bacteria that are responsible for environmental and nosocomial infections of clinical and biodefense concern. Our laboratory previously identified in silico Burkholderia collagen-like protein 8 (Bucl8) in the BSL-3 pathogens Burkholderia pseudomallei and Burkholderia mallei (Figure 1). The protein sequence of Bucl8 contains tandem outer-membrane efflux protein domains (OEP) typical of efflux systems and a unique collagen-like domain (CL) consisting of a repeating sequence of Glycine-Alanine-Serine (GAS). Because efflux pumps are often a mechanism of pathogenicity and antibiotic resistance, we investigated Bucl8 further. Here, we determined that the locus of bucl8 contains genes encoding a novel tripartite efflux pump that confers resistance to fusaric acid and pHBA, but not clinically-relevant antibiotics. Furthermore, deletion of the pump resulted delayed growth, suggesting a physiological role of the pump in human infectious strains. In addition to the prototypical barrel of outer membrane efflux proteins, Bucl8 has an extracellular GAS(n)-CL domain that forms a triple helix and binds fibrinogen. Moreover, we developed Burkholderia vaccine formulations based on the predicted immunogenic eipitopes of Bucl8, including the conserved, surface-exposed loops, L1 and L2, and portions of the collagen-like and C-terminal domains. Several combinations with different antigens, adjuvants, peptide conjugates, and routes of administration were tested for immunogenicity and/or protection in an intranasal challenge model utilizing outbred CD-1 mice and BSL-2 surrogate, B. thailandensis. The combination that reduced inflammation and disease the most was an intranasally administrated formulation of synthetic peptide of L1 conjugated to cross-reacting material 197 (CRM197) and adjuvanted with fluorinated cyclic diguanylate monophosphate (FCDG). Correlating disease outcomes with IgG antibody subtypes, T helper cell cytokines, and different myeloid cells, we determined that IL-10 correlated with morbidity, IgG2a with improved outcomes, and vaccination with reduced TH1/TH17 tissue-damaging cytokines. These humoral and cell-mediated correlates of protection could be used as biomarkers for diseases or applied to other therapeutics.
Degree
thesis:*- Name thesis:degree_name
- PhD
- Level thesis:degree_level
- Dissertation
- Discipline thesis:degree_discipline
- Microbiology, Immunology, and Cell Biology
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Grund, Megan Elizabeth
- Contributors dc:contributor
-
- Slawomir Lukomksi
- Mariette Barbier
- Jennifer Franko
- Paul LaSala
- Karen Martin
Subjects
dc:subject × 13Identifiers
dc:identifier.*- Identifier
-
<p><a href="https://orcid.org/0000-0003-4103-3151">https://orcid.org/0000-0003-4103-3151</a></p>
https://researchrepository.wvu.edu/etd/11659